Guest guest Posted March 15, 2005 Report Share Posted March 15, 2005 Dear Rupesh and all members, Now you know my mother's case. Hence I will not repeat it. Now our Dr. says that the Cyst is still there. It's size is 80mm x 50mm. Though, since last two months it has reduced by @ half. Dr. says that we should now drain it gastroscopely. ( Gastroscopic drainage ). What is your opinion? Pl. note that she has lost @ 20 kg in last three months and does'nt have apetite, has nautia etc. In view of this shall we go in for drainage? Also she needs to remove Gakk bladder. We dont know whether Dr. will also remove it or not. I am giving her story as on Nov. 2004 as under. Although She is now better and having above problems. Please advice. Thanks. -- Satish, India Story on 28/11/2004 Let me introduce myself. I am son of a mother who had Attack of Pancreatitis on 3rd Nov. 2004. As I have access to Internet & can converse on mails I am becoming member of PAI. My mother is @ 63 Year and have gall blader stones. Dr. had advised removal of it but due to BP problems she was not operated. Lateron we never took it seriously which appears to be big mistake! Now after going thr " usual stuff in Hospital she has been discharged since last 5 days. She is having nausiatic feelings and does not feel likke eating / drinking anything. She also had fever for one day after discharge. She even had fever in Hospital. Now no fever. But she is having lot of weekness and feels sick. No pains in stomoch. What is your opinion and advise? When will she recover? What diet she should take now? When should we remove her Gall Bladder? Will that stop this problem forever? Hope Rupesh has gone thr " similar and recovered hence my mother will also do so. Rupesh, can you please answer my questions? Thanks. Regards. -- Satish Suryawamshi SANGLI, INDIA 91-233-2303533 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 16, 2005 Report Share Posted March 16, 2005 Dear Satish, While I can not tell you what to do regarding your mother's pseudocyst, I can tell you that here in the U.S., it would be considered an appropriate procedure to laproscopically drain a pseudocyst of that size. For the last few months, the directions that the medical professionals have given you for your mother's care have been very much the same that would have been given here in the U.S. They advised you that it would be necessary to wait for a few months to allow the cyst to resolve some on it's own from it's previously huge size. It has reduced now to a size that is more suitable for safe gastroscopic drainage that should allow for a successful procedure. Since it was so large in the beginning, it would take a reasonably long period of time to reduce on it's own, so I think good progress has been made. Since it appears that the gallstones formed by your mother's gallbladder were the root of the problems that caused her pancreatitis to begin with, it would appear logical that the organ that caused all these problems should be removed. If the gallbladder wasn't removed, in all probability, it could again create stones that would obstruct the ducts again, and the whole process would repeat itself over again. This is why they advise for its removal. Everything that you've told us that the doctor's have advised you sounds to be like suitable, conservative medical practice for a woman of your mother's age. I would think that you should feel confident in the advice these doctor's have given you, and to trust them to continue with her drainage as planned, removal of her gallbladder, and her continuing health care. You must understand that I am not a doctor, and have no professional experience, only that experience I've had as a patient with chronic pancreatitis with two pseudocysts, and knowledge gained from reading and research. I'm including two medical articles for you to look at, one is about pancreatic pseudocysts, and the other is about drainage of cysts. With love, hope and prayers, Heidi Heidi H. Griffeth www.pancassociation.org/anthology#Heidi.html Bluffton, SC SC State & SE Regional Representative Pancreatitis Association, International Note: All comments or advice are personal opinion only, and should not be substituted for professional medical consultation. Pancreatic Pseudocysts Background: Single or multiple fluid collections giving the appearance of cysts on pancreatic imaging often are seen during acute pancreatitis. Because of the increasing sensitivity of imaging modalities and improvements in technology providing enhanced therapeutic abilities, the questions of when and whether drainage should be performed and what modality should be used to drain the cysts often are asked. Strictly defining the type of fluid collection is very important when reviewing pancreatic fluid collections. The therapeutic approach is different depending on the type of collection. Pseudocysts are best defined as a localized fluid collection that is rich in amylase and other pancreatic enzymes, has a nonepithelialized wall that consists of fibrous and granulation tissue, and usually appears several weeks after the onset of pancreatitis. This is in contrast with acute fluid collections, which are more evanescence in nature and are serosanguinous inflammatory reactions to acute pancreatitis. These are seen in pancreatitis that is more moderate to severe. They usually have an irregular shape and lack a well-defined wall. In general, these resolve in about 65% of cases. Two other types of fluid collection should be considered. First, organized necrosis actually is pancreatic tissue that is devitalized and appears cystlike on CT scan, but it appears to be solid on other imaging modalities. Second, an abscess is an infected area of necrosis or fluid. Pathophysiology: Pancreatic pseudocysts can be single or multiple. Multiple cysts are seen more frequently in alcoholic disease, and they can be multiple in about 15% of cases. Size can vary from 2-30 cm. About one third of pseudocysts present in the head of the gland, and two thirds present in the tail. The fluid in pseudocysts has been well characterized as either clear or watery, or it can be xanthochromic. The fluid in pseudocysts usually contains very high amounts of amylase, lipase, and trypsin, though amylase may decrease over time. The pathogenesis of pseudocysts seems to stem from disruptions of the pancreatic duct due to pancreatitis and extravasation of enzymatic material. Two thirds of patients with pseudocysts have demonstrable connections to the pancreatic duct. In the other one third, an inflammatory reaction is supposed to have sealed the connection so that it is not demonstrable. The cause of pseudocysts parallels the cause of acute pancreatitis; 75-85% of cases are caused by alcohol or gallstone disease–related pancreatitis. A frequent association exists between pseudocysts and trauma in children. Sex: A male predominance exists in the incidence of pseudocysts that mirrors the male predominance in the incidence of pancreatitis. Age: Pseudocysts may occur after pancreatitis in any age group. In children, pseudocysts most likely are seen after abdominal trauma. In elderly persons, take care not to confuse cystic neoplasms with pseudocysts. CLINICAL Section 3 of 11 History: * No specific set of symptoms that would lead a clinician to diagnosis a pseudocyst exists; however, suspect a pseudocyst in a patient who has persistent abdominal pain, anorexia, or abdominal mass after a case of pancreatitis. * Rarely, patients present with jaundice or sepsis from an infected pseudocyst. * Pleural effusion also is a common finding. Physical: * The sensitivity of physical examination is limited. * Very often, patients have a tender abdomen. * Occasionally, patients have a palpable mass in the abdomen. * Peritoneal signs suggest rupture of the cyst or infection. * Other possible findings include the following: * Fever * Scleral icterus * Pleural effusion Causes: Acute or chronic pancreatitis or abdominal trauma causes pseudocysts. If no history of pancreatitis or trauma exists, the diagnosis needs to be carefully confirmed. Lab Studies: * Serum tests have limited utility. * Amylase and lipase often are elevated but may be normal. * Bilirubin and liver function tests (LFTs) may be elevated if the biliary tree is involved. * Analysis of the cyst fluid may help differentiate pseudocysts from tumors. Attempt to rule out tumors in any patient who does not have a clear-cut history of pancreatitis. * Carcinoembryonic antigen (CEA) and carcinoembryonic antigen-125 (CEA-125) tumor markers are low in pseudocysts and high in tumors. * Fluid viscosity is low in pseudocysts and high in tumors. * Amylase usually is high in pseudocysts and low in tumors. * Cytology occasionally is helpful in diagnosing tumors, but a negative result does not exclude tumors. Imaging Studies: * Abdominal ultrasound: While cystic fluid collections in and around the pancreas may be visualized via ultrasound. The technique is limited by operator skill, the patient's habitus, and overlying bowel gas. As such, it is not the procedure of choice for diagnosis. * CT scan of the abdomen * CT scan is the imaging criterion standard. It has a sensitivity of 90-100% and is not operator dependent. * The usual finding on CT scan is a large cyst cavity in and around the pancreas. * Multiple cysts may be present. * The pancreas may appear irregular or have calcifications. * Pseudoaneurysms of the splenic artery, bleeding into a pseudocyst, biliary and enteric obstruction, and other complications may be seen on CT scan. * The CT scan provides a very good appreciation of the wall thickness of the pseudocyst, which is useful in planning therapy. * Endoscopic retrograde cholangiopancreatography * Endoscopic retrograde cholangiopancreatography (ERCP) is not necessary in diagnosing pseudocysts; however, it is useful in planning drainage strategy. * A study by Neil et al looking at the utility of ERCP and the treatment of pseudocysts and acute pancreatitis reported that 35% of the time a change in management occurred after the ERCP findings in pseudocysts were evaluated. Therefore, many authors recommend performing an ERCP before contemplated drainage procedures. * MRI * MRI is not necessary for the diagnosis of pseudocysts; however, it is useful in detecting a solid component to the cyst and differentiating between organized necrosis and a pseudocyst. * A solid component makes catheter drainage difficult; therefore, in the setting of acute necrotizing pancreatitis with resultant pseudocyst, an MRI may be very important before a planned catheter drainage procedure. * Endoscopic ultrasound * Endoscopic ultrasound (EUS) is not necessary for diagnosis but is very important in planning therapy, particularly if endoscopic drainage is contemplated. * A gastric wall with a thickness greater than 1 cm next to the cyst tends to predict a poor outcome with endoscopic drainage. * EUS also may be helpful in detecting small portal collaterals from otherwise undetected portal hypertension that may increase bleeding risks with transmural drainage. * Transmural drainage may only be performed when the symptomatic pseudocyst is positioned next to the gut wall. Histologic Findings: Histology varies with age because older cysts have thicker walls with increased collagen. The etiology of the cyst does not change the histology. TREATMENT Medical Care: The goal of therapy should be avoidance of complications. * About 10% of pseudocysts become infected. * Pseudocysts also can rupture. A controlled rupture into an enteric organ, at times, can cause GI bleeding. A free rupture into the peritoneal cavity produces abdominal pain and, on rare occasions, peritonitis or even death. * Most pseudocysts resolve without interference and only require supportive care. * Several studies have indicated that the size of the cyst and length of time the cyst has been present are poor predictors of complications. In general, larger cysts are more likely to become symptomatic or cause complications. However, some patients with larger collections do well. Therefore, size of the pseudocyst alone should not be an indication for drainage. * Indications for drainage * Complications * Symptoms * Concern about possible malignancy Surgical Care: Drainage options include the following: * Catheter drainage * Percutaneous aspiration is useful only for diagnosis or as a temporizing measure. It has a 54% failure rate and a 63% recurrence rate. Also, a relatively high risk of infecting the pseudocyst exists with this technique. * Percutaneous catheter drainage is the procedure of choice for treating infected pseudocysts, allowing for rapid drainage of the cyst and identification of any microbial organism. A high recurrence and failure rate exist, but catheter drainage may be a good temporizing measure. It is contraindicated in patients who are poorly compliant and cannot manage a catheter at home. It also is contraindicated in patients with strictures of the main pancreatic duct and in patients with cysts containing bloody or solid material. * Endoscopic drainage may be either transpapillary (via ERCP) or transmural. Both modalities require careful patient selection to ensure success and safety. * Transpapillary drainage, while safer and more effective than transmural drainage, requires cyst communication with the pancreatic duct. This technique also may be technically challenging because it requires wire passage and stenting through the pancreatic duct to the pseudocyst. The success rate is about 80%, the recurrence rate is 10-14%, and in most series, the complication rate (mainly pancreatitis) is approximately 13%. * Endoscopic transmural drainage also is possible. This involves performing an endoscopy and finding a bulge within the wall of the stomach or duodenum caused by compression of the pseudocyst. Then, the cyst is generally entered using a needle knife to cut through the gastric or duodenum wall, and a series of pigtail stents are placed through the resulting communication. The method has about an 82-89% success rate in very experienced hands. The recurrent rate is between 6% and 18%. The complication rate is 20%, with the most feared complication being bleeding. * Surgical drainage is the criterion standard that all the therapies need to be measured against. * Internal drainage is the procedure of choice. * In most series, a 3% mortality rate exists, and the complication rate is about 24%. * The success rate tends to be between 85% and 90%. Consultations: Management of pseudocysts requires a team approach. The gastroenterologist, the surgeon, and the invasive radiologist must all work together to determine the necessity, timing, and method of intervention. Diet: Patients may eat a low-fat diet, as tolerated. Patients in whom eating causes abdominal pain need either parenteral nutrition or enteral nutrition through a percutaneously or endoscopically placed jejunal tube. Activity: Activity as tolerated Further Outpatient Care: * Patients who have endoscopically placed stents must be monitored via serial CT scans to observe resolution of the cyst. Stents may then be removed endoscopically after resolution. * Closely monitor patients with percutaneous drains for pain, infection, or catheter migration. Remove the drain when drainage ceases. Complications: * Bleeding is the most feared complication. It is caused by the erosion of the pseudocyst into a vessel. * Suspect bleeding in any patient who has a sudden increase in abdominal pain coupled with a drop in hematocrit or a change in vital signs. * Therapy is emergent surgery or angiography with embolization of the bleeding vessel. * Do not perform a percutaneous or endoscopic drainage procedure under any circumstances in patients with suspected bleeding into a pseudocyst. * Suspect infection of the pseudocyst if the patients develop fever or an elevated white blood cell count. Treat infection with antibiotics and urgent drainage. * GI obstruction, presenting with nausea and vomiting, is an indication for drainage. * The pseudocyst also can rupture. * A controlled rupture into an enteric organ occasionally causes GI bleeding. * A profound rupture into the peritoneal cavity, on rare occasions, causes peritonitis and death. Prognosis: * Most pseudocysts resolve without interference, and patients do well without intervention. * If patients develop complications or need to have the cysts drained, the outcome is much worse. * The failure rate for drainage procedures is about 10%, the recurrence rate is about 15%, and the complication rate is 15-20% Patient Education: * Patients who are being managed expectantly must be educated about the warning signs for potential complications (eg, abdominal pain, fever), which may indicate bleeding, fever, or pseudocyst rupture. Satish wrote: > Now our Dr. says that the Cyst is still there. It's size is 80mm x 50mm. Though, since last two months it has reduced by @ half. > Dr. says that we should now drain it gastroscopely. ( Gastroscopic drainage ). What is your opinion? Pl. note that she has lost @ 20 kg in last three months and does'nt have apetite, has nautia etc. > In view of this shall we go in for drainage? Also she needs to remove Gakk bladder. We dont know whether Dr. will also remove it or not. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.